Skip to main content
In stock|Hormonal Therapy

Abiraterone Acetate

Oncology TypeSolid Tumour (Prostate)
Drug Class / MechanismCYP17 / Androgen Synthesis Inhibitor
No Image
Description

Abiraterone Acetate is classified as a CYP17 / Androgen Synthesis Inhibitor, sourced for use within our Hormonal Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryHormonal Therapy
Oncology TypeSolid Tumour (Prostate)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3